# Jot Chahal, Angel Investor

Investor in Princeton, New Jersey

## About Jot Chahal, Angel Investor

Jot Chahal is an Angel Investor, Global VP of Johnson & Johnson, and Digital Health Committee Member of BioNJ.

Jot is an entrepreneurial and results-driven health technology executive with twenty years of experience in driving top-line profitable growth through innovation, and data-driven strategies across industries, services, and markets globally. He is on a mission to transform healthcare through advanced analytics, AI, wearable sensing, and the Internet of medical things.

HIS AREAS OF EXPERTISE

STRATEGY & GROWTH: • Growth Strategy Development • Business Model Development • M&A Evaluation & Due Diligence • Acquisition Integration • Partnership Development & Management

LEADERSHIP & CULTURE CHANGE: • Team Leadership & Trust Building • Change Management • Global Matrix Collaboration • Talent & Bench Strength Development • Process Renewal & Adoption

HEALTHCARE MARKETING & INNOVATION: • Strategic & Downstream Marketing • Clinical Evidence Generation • Market Research & Segmentation • Corporate Branding • Integrated Marketing Communication & Messaging

## People

- **Jot Chahal**, Angel Investor

## Key Facts

- **Location:** Princeton, New Jersey
- **Investor Type:** Angel Investor

## Investment Industries

- Medical/Healthcare
- Technology/Web/App
- Other

## How to Contact

Direct messaging, this investor's website, and their Facebook profile are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/jot-chahal-angel-investor
- More investors: [Medical Investors in New Jersey](https://askforfunding.com/site/angel-investors/new-jersey/medical)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.
